10x Genomics (TXG) Other Operating Expenses (2018 - 2026)

10x Genomics has disclosed Other Operating Expenses across 7 years of filings, most recently posting -$3.4 million for Q2 2026.

• In Q2 2026, Other Operating Expenses rose 91.65% year-over-year to -$3.4 million; the TTM figure through Jun 2026 stood at -$3.4 million (up 93.19% YoY), while the FY2025 annual figure was -$49.9 million, changed N/A from the prior year.
• Other Operating Expenses came in at -$3.4 million for Q2 2026 at 10x Genomics, up from -$40.7 million in the prior quarter.
• In the past five years, Other Operating Expenses ranged from a high of $41.4 million in Q3 2023 to a low of -$40.7 million in Q2 2025.
• Average Other Operating Expenses over 3 years is $1.5 million, with a median of -$3.4 million recorded in 2026.
• The largest YoY upside for Other Operating Expenses was 91.65% in 2026 against a maximum downside of 91.65% in 2026.
• Over 3 years, Other Operating Expenses stood at $19.6 million in 2023, then tumbled by 307.89% to -$40.7 million in 2025, then surged by 91.65% to -$3.4 million in 2026.
• Per Business Quant data, the three most recent Other Operating Expenses figures were -$3.4 million in Q2 2026, -$40.7 million in Q2 2025, and -$9.2 million in Q1 2025.